The estimated Net Worth of Andrew H Lane is at least $10.8 million dollars as of 15 November 2021. Mr. Lane owns over 10,000 units of Abbott Laboratories stock worth over $8,871,744 and over the last 9 years he sold ABT stock worth over $1,910,600. In addition, he makes $0 as Executive Vice President - Established Pharmaceuticals at Abbott Laboratories.
Andrew has made over 5 trades of the Abbott Laboratories stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 10,000 units of ABT stock worth $1,300,100 on 15 November 2021.
The largest trade he's ever made was exercising 135,925 units of Abbott Laboratories stock on 27 August 2021 worth over $5,219,520. On average, Andrew trades about 10,636 units every 40 days since 2015. As of 15 November 2021 he still owns at least 76,087 units of Abbott Laboratories stock.
You can see the complete history of Mr. Lane stock trades at the bottom of the page.
Andrew H. Lane serves as Executive Vice President - Established Pharmaceuticals of the Company. From 2014 to 2015 served with Divisional Vice President, Established Pharmaceuticals, Asia Pacific. Between 2011 to 2014 Lane is Vice President, Asia Pacific, Takeda Pharmaceutical Company Limited (a Japanese pharmaceutical company).
Andrew Lane is 49, he's been the Executive Vice President - Established Pharmaceuticals of Abbott Laboratories since 2017. There are 37 older and 5 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 75, who is the Independent Director.
Andrew's mailing address filed with the SEC is 100 ABBOTT PARK ROAD, , ABBOTT PARK, IL, 60064.
Over the last 24 years, insiders at Abbott Laboratories have traded over $388,257,551 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 . The most active insiders traders include Miles D White, Richard A Gonzalez et Jeffrey M Leiden. On average, Abbott Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,003,344. The most recent stock trade was executed by John A. Jr. Mccoy on 1 September 2024, trading 27 units of ABT stock currently worth $3,100.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
Abbott Laboratories executives and other stock owners filed with the SEC include: